Eloxx Pharmaceuticals Inc

-0.04 (-29.56%)
7:58:40 PM EDT: $0.10 0.00 (4.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Eloxx Pharmaceuticals Inc Stock, NASDAQ:ELOX

480 Arsenal Way, Suite 130, Watertown, Massachusetts 02451
United States of America
Phone: +1.781.577.5300
Number of Employees: 28


Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Watertown, MA.